Predictors of immune function in space flight

Acta Astronautica

Volumn 60, Issue 4-7 SPEC. ISS., 2007, Pages 247-253

  Shearer, William T ^a   Zhang, Shaojie ^b   Reuben, James M ^c   Lee, Bang Ning ^c   Butel, Janet S ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Interferon gamma; Latent virus reactivation; Polyoma virus infection; Radiation; Space flight; T lymphocytes

Indexed keywords

DISEASES; EARTH (PLANET); ENVIRONMENTAL IMPACT; GAMMA RAYS; SPACE FLIGHT; VIRUSES;

EARTH-BOUND RADIATIONS; HUMAN IMMUNITY; LATENT VIRUS REACTIVATION; POLYOMA VIRUS INFECTION;

IMMUNOLOGY;

EID: 33846610031     PISSN: 00945765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actaastro.2006.08.005     Document Type: Article

References (38)

1. Sonnenfeld G., Butel J.S., and Shearer W.T. Effects of the space flight environment on the immune system. Reviews on Environmental Health 18 (2003) 1-17
2. Konstantinova I.V., Rykova M.P., Lesnyak A.T., and Antropova E.A. Immune changes during long-duration missions. Journal of Leukocyt Biology 54 (1993) 189-201
3. Shearer W.T., and Sonnenfeld G. Alterations of immune responses in space travel. In: Hans M. (Ed). Encyclopedia of Space Science and Technology (2003), Wiley, New York 810-838
4. Schmitt D.A., Schaffar L., Taylor G.R., Loftin K.C., Schneider V.S., Koebel A., et al. Use of bed rest and head-down tilt to simulate spaceflight-induce immune system changes. Journal of Interferon and Cytokine Research 16 (1996) 151-157
5. Shearer W.T., Lugg D.J., Rosenblatt H.M., Nickolls P.M., Sharp R.M., Reuben J.M., et al. Antibody responses to bacteriophage phi X-174 in human subjects exposed to the antarctic winter-over model of spaceflight. Journal of Allergy and Clinical Immunology 107 (2001) 160-164
6. Shearer W.T., Reuben J.M., Mullington J.M., Price N.J., Lee B.N., Smith E.O., et al. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. Journal of Allergy and Clinical Immunology 107 (2001) 165-170
7. Shearer W.T., Lee B.N., Cron S.G., Rosenblatt H.M., Smith E.O., Lugg D.J., et al. Suppression of human anti-inflammatory plasma cytokines IL-10 and IL-1RA with elevation of proinflammatory cytokine IFN-gamma during the isolation of the Antarctic winter. Journal of Allergy and Clinical Immunology 109 (2002) 854-857
8. Tingate T.R., Lugg D.J., Muller H.K., Stowe R.P., and Pierson D.L. Antarctic isolation: immune and viral studies. Immunology and Cell Biology 75 (1997) 275-283
9. Payne D.A., Mehta S.K., Tyring S.K., Stowe R.P., and Pierson D.L. Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. Aviation Space and Environmental Medicine 70 (1999) 1211-1213
10. Taylor G.R., Konstantinova I., Sonnenfeld G., and Jennings R. Changes in the immune system during and after spaceflight. Advances in Space Biology and Medicine 6 (1997) 1-32
11. Mehta S.K., Pierson D.L., Cooley H., Dubow R., and Lugg D. Epstein-Barr virus reactivation associated with diminished cell-mediated immunity in Antarctic expeditioners. Journal of Medical Virology 61 (2000) 235-240
12. Lednicky J.A., Vilchez R.A., Keitel W.A., Visnegarwala F., White Z.S., Kozinetz C.A., et al. PyV JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 17 (2003) 801-807
13. Ling P.D., Vilchez R.A., Keitel W.A., Poston D.G., Peng R.S., White Z.S., et al. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clinical Infectious Diseases 37 (2003) 1244-1249
14. Stowe R.P., Mehta S.K., Ferrando A.A., Feeback D.L., and Pierson D.L. Immune responses and latent herpes virus reactivation in spaceflight. Aviation Space and Environmental Medicine 72 (2001) 884-891
15. Stowe R.P., Pierson D.L., and Barrett A.D. Elevated stress hormone levels relate to Epstein-Barr virus reactivation in astronauts. Psychosomotic Medicine 63 (2001) 891-895
16. Shirai T., Magara K.K., Motohashi S., Yamashita M., Kimura M., Suwazomo Y., et al. TH1-biased immunity induced by exposure to Antarctic winter. Journal of Allergy and Clinical Immunology 111 (2003) 1353-1360
17. Moore F.D. Radiation burdens for humans on prolonged exomagnetospheric voyages. FASEB Journal 6 (1992) 2338-2343
18. Croul S., Otte J., and Khalili K. Brain tumors and polyomaviruses. Journal of Neurovirology 9 (2003) 173-182
19. Kajioka E.H., Andres M.L., Li J., Mao X.W., Moyers M.F., Nelson G.A., et al. Acute effects of whole-body proton irradiation on the immune system of the mouse. Radiation Research 153 (2000) 587-594
20. Kajioka E.H., Gheorghe C., Andres M.L., Abell G.A., Folz-Holbeck J., Slater J.M., et al. Effects of proton and gamma radiation on lymphocyte populations and acute response to antigen. In Vivo 13 (1999) 525-533
21. Kajioka E.H., Andres M.L., Mao X.W., Moyers M.F., Nelson G.A., and Gridley D.S. Hematological and TGF-beta variations after whole-body proton irradiation. In Vivo 14 (2000) 703-708
22. Gridley D.S., Pecaut M.J., Dutta-Roy R., and Nelson G.A. Dose and dose rate effects of whole-body proton irradiation on leukocyte populations and lymphoid organs: part I. Immunology Letters 80 (2002) 55-66
23. Pecaut M.J., Gridley D.S., Smith A.L., and Nelson G.A. Dose and dose rate effects of whole-body proton-irradiation on lymphocyte blastogenesis and hematological variables: part II. Immunology Letters 80 (2002) 67-73
24. Butel J.S. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21 (2000) 405-426
25. Vilchez R.A., Madden C.R., Kozinetz C.A., Halvorson S.J., White Z.S., Jorgensen J.L., et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 359 (2002) 817-823
26. Berke Z., and Dalianis T. Studies on polyomavirus persistence and polyomavirus-induced tumor development in relation to the immune system. Advances in Cancer Research 79 (2000) 249-276
27. Moser J.M., and Lukacher A.E. Immunity to polyomavirus infection and tumorigenesis. Viral Immunology 14 (2001) 199-216
28. Cucinotta F.A., Schimmerling W., Wilson J.W., Peterson L.E., Badhwar G.D., Saganti P.B., et al. Space radiation cancer risks and uncertainties for Mars missions. Radiation Research 156 (2001) 682-688
29. Wilson J.W., Cucinotta F.A., Miller J., Shinn J.L., Thibeault S.A., Singleterry R.C., et al. Approach and issues relating to shield material design to protect astronauts from space radiation. Materials and Design 22 (2001) 541-554
30. Shearer W.T., Zhang S., Reuben J.M., Lee B.N., and Butel J.S. Effects of radiation and latent virus on immune responses in a space flight model. Journal of Allergy and Clinical Immunology 115 (2005) 1297-1303
31. Todd P., Pecaut M.J., and Fleshner M. Combined effects of space flight factors and radiation on humans. Mutation Research 430 (1999) 211-219
32. Thorley-Lawson D.A. EBV the prototypical human tumor virus-just how bad is it?. Journal of Allergy and Clinical Immunology 116 (2005) 251-261
33. Shearer W.T., Ritz J., Finegold M.J., Guerra I.C., Rosenblatt H.M., Lewis D.E., et al. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. New England Journal of Medicine 312 (1985) 1151-1159
34. Hochberg D., Middeldorp J.M., Catalina M., Sullivan J.L., Luzuriaga K., and Thorley-Lawson D.A. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proceedings of the National Academy of Sciences 101 (2004) 239-244
35. Hochberg D.R., and Thorley-Lawson D.A. Quantitative detection of viral gene expression in populations of Epstein-Barr virus-infected cells in vivo. Methods in Molecular Biology 292 (2005) 39-56
36. Stamatis N.C., Liossis M.D., and Tsokos G.C. Monoclonal antibodies and fusion proteins in medicine. Journal of Allergy and Clinical Immunology 116 (2005) 721-729
37. Presta L.G. Selection, design, and engineering of therapeutic antibodies. Journal of Allergy and Clinical Immunology 116 (2005) 731-736
38. Ballow M. -ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?. Journal of Allergy and Clinical Immunology 116 (2005) 738-743